2009
DOI: 10.1080/22201009.2009.10872209
|View full text |Cite
|
Sign up to set email alerts
|

Insulin resistance induced by antiretroviral drugs: Current understanding of molecular mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 39 publications
(45 reference statements)
0
3
0
Order By: Relevance
“…The activation of Akt through its translocation to the membrane is directly assisted by PIP 3 via the pleckstrin homology domain. Akt has an important and central role in insulin-stimulated glucose uptake, as it is a major target in PI3-K activities, directly associating upstream insulin signalling with Glucose Transporter 4 (GLUT4) translocation [ 17 ]. Metabolic enzymes like glycogen synthase kinase 3 and 6-phosphofructo-2-kinase are regulated by Akt activation—apart from it stimulating the translocation of GLUT4 to the plasma membrane from the intracellular storage compartment, in order to take up the ingested extracellular glucose ( Figure 1 ) [ 17 ].…”
Section: Insulin-signalling Pathwaymentioning
confidence: 99%
“…The activation of Akt through its translocation to the membrane is directly assisted by PIP 3 via the pleckstrin homology domain. Akt has an important and central role in insulin-stimulated glucose uptake, as it is a major target in PI3-K activities, directly associating upstream insulin signalling with Glucose Transporter 4 (GLUT4) translocation [ 17 ]. Metabolic enzymes like glycogen synthase kinase 3 and 6-phosphofructo-2-kinase are regulated by Akt activation—apart from it stimulating the translocation of GLUT4 to the plasma membrane from the intracellular storage compartment, in order to take up the ingested extracellular glucose ( Figure 1 ) [ 17 ].…”
Section: Insulin-signalling Pathwaymentioning
confidence: 99%
“…IR occurs when normal insulin levels are no sufficient to stimulate glucose uptake in the insulin signaling pathway in insulin-sensitive tissues such as muscle, liver, and subcutaneous adipose tissue. Following manifestations such as hyperinsulinemia, hyperglycemia, and dislipidemia (hypertriglyceridemia) are seen in patients with protease inhibitors [18,19].…”
Section: Discussionmentioning
confidence: 99%
“…The cytokine induces activation of serine kinases such as JNK and IKK, which serine phosphorylates IRS-1. The increased concentration of phosphorylated IRS-1 inhibits the insulin receptor, thus causing insulin resistance [ 75 ].…”
Section: Protease Inhibitorsmentioning
confidence: 99%